These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8992950)

  • 1. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.
    Salminen S; Isolauri E; Salminen E
    Antonie Van Leeuwenhoek; 1996 Oct; 70(2-4):347-58. PubMed ID: 8992950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics and stabilisation of the gut mucosal barrier.
    Salminen S; Isolauri E; Salminen E
    Asia Pac J Clin Nutr; 1996 Mar; 5(1):53-6. PubMed ID: 24394468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of lactic acid bacteria in treatment and prophylaxis of digestive tract disorders].
    Strus M
    Postepy Hig Med Dosw; 1997; 51(6):605-19. PubMed ID: 9481894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic microorganisms: how they affect intestinal pathophysiology.
    Heyman M; Ménard S
    Cell Mol Life Sci; 2002 Jul; 59(7):1151-65. PubMed ID: 12222962
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between the microbiota and the intestinal mucosa.
    Schiffrin EJ; Blum S
    Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S60-4. PubMed ID: 12142966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
    Candela M; Perna F; Carnevali P; Vitali B; Ciati R; Gionchetti P; Rizzello F; Campieri M; Brigidi P
    Int J Food Microbiol; 2008 Jul; 125(3):286-92. PubMed ID: 18524406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens.
    Servin AL; Coconnier MH
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):741-54. PubMed ID: 14507585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.
    Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB
    Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
    Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
    HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity, inflammation, and allergy in the gut.
    Macdonald TT; Monteleone G
    Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria.
    Ouwehand AC; Salminen S; Tölkkö S; Roberts P; Ovaska J; Salminen E
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):184-6. PubMed ID: 11777852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro.
    Ouwehand AC; Niemi P; Salminen SJ
    FEMS Microbiol Lett; 1999 Aug; 177(1):35-8. PubMed ID: 10436921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics: effects on immunity.
    Isolauri E; Sütas Y; Kankaanpää P; Arvilommi H; Salminen S
    Am J Clin Nutr; 2001 Feb; 73(2 Suppl):444S-450S. PubMed ID: 11157355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.
    Collado MC; Jalonen L; Meriluoto J; Salminen S
    Asia Pac J Clin Nutr; 2006; 15(4):570-5. PubMed ID: 17077078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants.
    He F; Ouwehand AC; Isolauri E; Hashimoto H; Benno Y; Salminen S
    FEMS Immunol Med Microbiol; 2001 Feb; 30(1):43-7. PubMed ID: 11172990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.